Flexion Therapeutics Inc (FLXN)

22.12
NASDAQ : Health Care
Prev Close 22.04
Day Low/High 21.83 / 22.41
52 Wk Low/High 15.44 / 29.41
Avg Volume 574.00K
Exchange NASDAQ
Shares Outstanding 31.91M
Market Cap 703.20M
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: Ocular, Alder, Flexion

Biotech Movers: Ocular, Alder, Flexion

Ocular Therapeutix, Alder BioPharmaceuticals, Flexion Therapeutics were among the biotech stock movers in premarket trading on July 12.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

Flexion Therapeutics Named One Of Boston Business Journal's Best Places To Work

Bold culture earns company recognition in medium business category

First Week of FLXN February 2018 Options Trading

Investors in Flexion Therapeutics, Inc. saw new options begin trading this week, for the February 2018 expiration.

Biotech Movers: Coherus, XBiotech, Flexion

Biotech Movers: Coherus, XBiotech, Flexion

Coherus BioSciences, XBiotech and Flexion Therapeutics were among the biotech stock movers in premarket trading on Monday.

Flexion Therapeutics To Present Data On Zilretta™ (FX006) At The American Diabetes Association's 77th Scientific Sessions

Full findings from Phase 2 study in patients with knee osteoarthritis and Type 2 diabetes show Zilretta avoids the significant rise in blood glucose seen with an immediate-release corticosteroid

Flexion Therapeutics is Now Oversold (FLXN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

FLXN: Insiders vs. Shorts

The most recent short interest data was recently released for the 05/15/2017 settlement date, and Flexion Therapeutics, Inc. is one of the most shorted stocks of the Russell 3000, based on 5.76 "days to cover" versus the median component at 4.71.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

Short Interest Increases 103.8% For FLXN

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 2,281,535 share increase in total short interest for Flexion Therapeutics, Inc. , to 4,478,675, an increase of 103.84% since 04/28/2017.

2 Oversold Biopharmas With Big 2017 Upsides

2 Oversold Biopharmas With Big 2017 Upsides

Flexion Therapeutics and BioDelivery Sciences are well below what they once fetched.

Flexion Therapeutics Announces Upcoming Data Presentation At The American Diabetes Association's 77th Scientific Sessions

Presentation to include full results from Phase 2 study evaluating Zilretta™ (FX006) in patients with Type 2 diabetes and osteoarthritis of the knee

First Week of FLXN November 17th Options Trading

Investors in Flexion Therapeutics, Inc. saw new options begin trading this week, for the November 17th expiration.

Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka

Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka

Akebia after the market close on Tuesday announced an expanded partnership with Japan's Otsuka Pharmaceuticals to develop and market its anemia pill Vadadustat in Europe, China and other territories.

Shark Bites: You Don't Want to Play the Gambler Today

Shark Bites: You Don't Want to Play the Gambler Today

This is one of those days when it may pay to walk away.

Second-Quarter Picks and Pans

Second-Quarter Picks and Pans

Las Vegas Sands and Flexion are in, and the autos are out.